Close Asset Management’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-28
| Closed | – | – | 257 |
|
|
2025
Q1 | $0 | Hold |
28
| – | – | ﹤0.01% | 255 |
|
|
2024
Q4 | $0 | Hold |
28
| – | – | ﹤0.01% | 249 |
|
|
2024
Q3 | $0 | Hold |
28
| – | – | ﹤0.01% | 266 |
|
|
2024
Q2 | $0 | Hold |
28
| – | – | ﹤0.01% | 270 |
|
|
2024
Q1 | $1K | Hold |
28
| – | – | ﹤0.01% | 250 |
|
|
2023
Q4 | $2K | Hold |
28
| – | – | ﹤0.01% | 231 |
|
|
2023
Q3 | $2K | Buy |
+28
| New | +$2K | ﹤0.01% | 224 |
|
|
2023
Q2 | – | Sell |
-55
| Closed | -$3K | – | 255 |
|
|
2023
Q1 | $3K | Hold |
55
| – | – | ﹤0.01% | 218 |
|
|
2022
Q4 | $4K | Hold |
55
| – | – | ﹤0.01% | 183 |
|
|
2022
Q3 | $7K | Hold |
55
| – | – | ﹤0.01% | 163 |
|
|
2022
Q2 | $5K | Hold |
55
| – | – | ﹤0.01% | 171 |
|
|
2022
Q1 | $18K | Hold |
55
| – | – | ﹤0.01% | 172 |
|
|
2021
Q4 | $18K | Hold |
55
| – | – | ﹤0.01% | 172 |
|
|
2021
Q3 | $25K | Buy |
+55
| New | +$25K | ﹤0.01% | 158 |
|